Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (73)	9/14/2000 1:35:05 AM
From: scaram(o)uche	Respond to of 598

ooooops, looked it up.... was Vector, but Drake not Toth. (eom)

To: scaram(o)uche who wrote (73)	9/14/2000 1:47:59 AM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 598

For a while I am following KDUS/OSIP/SNAP/DDDP/TLRK/ARNA/...work on GPCRs as well as orphan receptors. However, can't say who has here advantage or whose method is valid and sound, and whose not. Also, what are characteristic of their work and where are difference is so big issue that several studies will not give final answers. The easy way is to follow specific program (at each company) and see how program progress correlate with what company call platform technology. Miljenko PS: Need place and time for tomorrow night (if at all)?

To: scaram(o)uche who wrote (73)	9/15/2000 12:17:58 AM
From: tommysdad	Read Replies (1) \| Respond to of 598

<<Arena and 3-Dimensional Pharm.>> Sorry, should have been more clear. I was inquiring after other players in the nuclear orphan area. Not familiar with 3-D, but Arena is the "CART technology" company, right? They're only looking at GPCRs at this time. (One has to question the viability of this technology for drug discovery . . . but perhaps an ARNA is in order) Anyway, what gets me about the nuclear orphan crowd (TLRK/GLX/X-ceptor) is that they all seem to have gravitated to the same few targets -- LXR & FXR. Isn't anyone looking anywhere else? Do Tularik and X-Ceptor really think they're going to beat Glaxo to the punch?